IL10 and hepatitis C virus infection: Several biomarkers have been shown to predict clinical acute rejection, including primary biliary cirrhosis, younger age, hepatitis C [41], IL-10-1082 polymorphism [42], de novo donor-specific antibody [20], and cytokine promoter polymorphisms [43].